Achiko Completes Initial Shipment of AptameX, its Progressive Covid-19 Diagnostic Test to Indonesia, Delivering 77% Sensitivity at Low Viral Loads Production of First 1,000 AptameX Test Kits is Concluded in Singapore (initial capacity to test 10,000 patients per day).AptameX Delivers Sensitivity of 77% (95% CI: 75.94 - 79.24) at a High Industry...

Achiko Appoints New Chief Financial Officer and Announces Changes to Senior Team Appoints Robert Rieder as Chief Financial OfficerChief Operating Officer Chris Young to Retire Focus on Product Development, Lowering Cost Profile and Improved Alignment of Resources ZURICH,...

Achiko Concludes Phase 1 Study of Project Gumnuts for Covid-19 Testing Completion of Phase 1 Testing Demonstrates 91% Sensitivity and 85% SpecificityFurther Optimization Studies are Currently Being Performed and are Expected to Continue to Improve Results and Match WHO...

Achiko Strengthens Leadership Team with New President and New SVP Commercialization Appoints New President, Biotechnology Research Scientist and Entrepreneur Dr. Morris S. Berrie Appoints New SVP Commercialization, Business Leader in Life Science Richard Lingard New Senior Leadership...

Achiko Partners with Udayana University for Covid-19 Testing Research in Bali, Indonesia Achiko signed a research agreement with Udayana University’s Research Department to study the practicability of a mass testing approach with Teman Sehat and Gumnuts when availableThe Study will focus...